Friday 6 November 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue: +7.64%
EPS: −12.4%
Free cash flow: −19.4%
Total debt: −10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%

Follow SYK

Alert me

Market cap: $127.6B
P/E: 35.3×
Fwd P/E: 24.6×
Dividend yield: 1.05%
F-score: 5/9
Altman Z: 4.81
Beneish M: −2.62
Dividend safety: 82/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Stryker Corporation (SYK) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Stryker Corporation (SYK) trades at a price to free cash flow of 28.9×. Over the past ten years it has ranged from 17.0× (November 2016) to 279× (October 2017); the current reading is higher than 14% of that period. That is in line with the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SYK/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Stryker Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SYK/metrics/price-to-free-cash-flow">Stryker Corporation (SYK) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	31.4×	(20.27%)
FY2024	39.3×	9.71%
FY2023	35.9×	(21.54%)
FY2022	45.7×	24.12%
FY2021	36.8×	11.65%
FY2020	33.0×	(35.23%)
FY2019	50.9×	76.97%
FY2018	28.8×	(53.18%)
FY2017	61.5×	95.99%
FY2016	31.4×	(36.31%)

Period	Price to free cash flow	Change
Sep 2026	23.9×	(7.01%)
Jun 2026	25.7×	(6.71%)
Mar 2026	27.5×	(12.24%)
Dec 2025	31.4×	(5.97%)
43 more quarters	Free account

Against its own ten years

Low 17.0× High 279×

Ten-year median 39.0×

Current reading's percentile 14

Company	Price to free cash flow
PHG Koninklijke Philips N.V. compare	14.1×
BSX Boston Scientific Corporation compare	19.3×
GEHC GE HealthCare Technologies Inc. compare	19.9×
MDT Medtronic PLC compare	21.8×
ABT Abbott Laboratories compare	25.2×
STE STERIS plc compare	26.4×
DXCM DexCom, Inc. compare	28.8×
SYK Stryker Corporation	28.9×
EW Edwards Lifesciences Corporation compare	41.5×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Stryker Corporation (SYK) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SYK

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on SYK

Stockrow Weekly